SCHEMBL7304583

SCHEMBL7304583

O=C(O)OCc1cnccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
NAPRT Q6XQN6 1/20 0.44
HCAR2 Q8TDS4 1/20 0.44
VNN1 O95497 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
SYK P43405 1/20 0.39
TSHR P16473 3/20 0.38
ADORA3 P0DMS8 1/20 0.38
MC4R P32245 1/20 0.38
ADRA1A P35348 1/20 0.38
MC3R P41968 1/20 0.38
LMNA P02545 3/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GRM5 P41594 1/20 0.37
PSMB5 P28074 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10491331 0.83 SYK (0.43) KDM4ENAPRTHCAR2VNN1HDAC3
SCHEMBL11403418 0.80 SYK (0.39) KDM4ENAPRTHCAR2VNN1HDAC3
SCHEMBL28677212 0.80 TDP1 (0.57) KDM4EVNN1TSHRLMNASMN1; SMN2
SCHEMBL11400559 0.79 THRB (0.38) KDM4ENAPRTHCAR2VNN1HDAC3
SCHEMBL11397020 0.79 KDM4E (0.43) KDM4ENAPRTHCAR2VNN1HDAC3
SCHEMBL361616 0.78 GRM5 (0.46) KDM4ENAPRTHCAR2VNN1HDAC3
SCHEMBL7337933 0.77 TSHR (0.50) VNN1SYKTSHRLMNANPC1
SCHEMBL31471130 0.76 SYK (0.38) KDM4EVNN1HDAC3HDAC1HDAC2
SCHEMBL19582171 0.75 PSMB5 (0.37) KDM4EVNN1HDAC3HDAC1HDAC2
SCHEMBL20809783 0.75 MAPK1 (0.38) KDM4EHDAC3HDAC1HDAC2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107207504-A Phthalazinone derivatives, preparation method and the usage 四川科伦博泰生物医药股份有限公司 2017-09-26 CN disclosed
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed